Gliomas with IDH mutations, 1p19q codeletions, and MGMT promoter methylation demonstrated significantly lower RSF scores compared to their respective control groups, indicating that RSF scores may reflect underlying molecular alterations (Figure 4A). This evidence concerns the gene MGMT and central nervous system cancer.